Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of AT1 Receptor in Coronary Vascular Function
NCT00001629Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jul 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of losartan in atherosclerosis, heart failure (HF), hypertension (HTN), coronary artery disease (CAD), sponsored by National Heart, Lung, and Blood Institute. Started Jul 1997; status: completed.
02
Drugs
losartan
03
Conditions
atherosclerosisheart failure (HF)hypertension (HTN)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00001629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001629.